Warning Letter — eliquidflavourconcentrates.co.uk
The FDA's Center for Tobacco Products issued a warning letter to eliquidflavourconcentrates.co.uk for regulatory violations. The specific nature of the violations was not detailed in the provided excerpt beyond the issuance of the letter itself.
This affects eliquidflavourconcentrates.co.uk and potentially other international e-liquid retailers and manufacturers who distribute products within FDA jurisdiction.
The issuance of a warning letter by the Center for Tobacco Products indicates that the firm's operations or products failed to meet statutory requirements. This suggests that the FDA is actively monitoring international e-commerce platforms for compliance with U.S. tobacco regulations, highlighting a continued focus on enforcement within the nicotine-delivery product market.
Firms exporting tobacco-derived products or e-liquids to the U.S. should audit their product listings to ensure no unapproved products are available for purchase. Regulatory teams should monitor CTP enforcement actions against international e-commerce entities to ensure cross-border compliance.
FDA Warning Letter issued to: eliquidflavourconcentrates.co.uk. 07/02/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eliquidflavourconcentratescouk-733423-07022026
Open in openFDA / FDA.gov